JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB202073

Anti-CD24 antibody [EPR19925]

4

(3 Reviews)

|

(27 Publications)

Rabbit Recombinant Monoclonal CD24 antibody. Suitable for Flow Cyt, ICC/IF and reacts with Human samples. Cited in 27 publications.

View Alternative Names

CD24, CD24A, Signal transducer CD24, Small cell lung carcinoma cluster 4 antigen

4 Images
Flow Cytometry - Anti-CD24 antibody [EPR19925] (AB202073)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-CD24 antibody [EPR19925] (AB202073)

Flow cytometric analysis of MDA-MB-231 (human breast adenocarcinoma cell line, Left) and MCF7 breast adenocarcinoma cell line, Right) cell lines labeling CD24 with ab202073 at 1/500 (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Gated on total viable cells. Negative control : MDA-MB-231 (PMID : 18433506 and 22934288).

Immunocytochemistry/ Immunofluorescence - Anti-CD24 antibody [EPR19925] (AB202073)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-CD24 antibody [EPR19925] (AB202073)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized MCF7 (human breast adenocarcinoma cell line) and MDA-MB-231 (human breast adenocarcinoma cell line) cells labeling CD24 with ab202073 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous staining on MCF7 cell line.

Negative control : MDA-MB-231 (PMID : 18433506).

The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Flow Cytometry - Anti-CD24 antibody [EPR19925] (AB202073)
  • Flow Cyt

Lab

Flow Cytometry - Anti-CD24 antibody [EPR19925] (AB202073)

Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab202073 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left). PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody ab202073 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 5.0 μg/ml (1/400)) for 30min on ice. The cells were simultaneously stained with CD3.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min on ice

Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.

Flow Cytometry - Anti-CD24 antibody [EPR19925] (AB202073)
  • Flow Cyt

Lab

Flow Cytometry - Anti-CD24 antibody [EPR19925] (AB202073)

Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab202073 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left). PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody ab202073 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 5.0 μg/ml (1/400)) for 30min on ice. The cells were simultaneously stained with CD19.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min on ice

Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.

  • Carrier free

    Anti-CD24 antibody [EPR19925] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CD24 antibody [EPR19925]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-CD24 antibody [EPR19925]

  • 660 APC

    APC Anti-CD24 antibody [EPR19925]

  • 578 PE

    PE Anti-CD24 antibody [EPR19925]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19925

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD24 also known as heat-stable antigen or CD24A is a glycosylphosphatidylinositol (GPI)-anchored membrane protein with a molecular mass of approximately 30-50 kDa. It is expressed on the surface of many cell types including B cells T cells neutrophils and epithelial cells. CD24 plays a role in cell adhesion and signaling processes impacting immune response and cancer progression. Its expression is often used as a marker in identification and classification procedures such as flow cytometry.
Biological function summary

CD24 functions like a molecular "switch" modulating signals sent between cells. It acts as a ligand for multiple receptors and participates in cellular communication especially influencing the immune system. Part of its biological role involves interaction within cellular complexes impacting immune modulation and inflammatory responses. CD24's location at the interface of cellular microenvironments makes it critical for cellular response adaptation to varied external stimuli.

Pathways

CD24 participates in both immune signaling and cancer-related pathways. It plays a significant role in the suppression of the immune response often interacting with proteins like Siglec-10 in these pathways. CD24's involvement in these pathways contributes to cell survival and proliferation particularly within cancer development. The protein’s interaction within specified signaling pathways allows it to influence downstream targets that regulate gene expression and cellular functions.

CD24 has significant connections to cancer and inflammatory diseases. It is highly expressed in various cancers including breast and prostate cancer where it correlates with poor prognosis due to its role in apoptosis evasion and metastasis. CD24 interacts with proteins like HMGB1 and is implicated in inflammatory conditions where it modulates immune cell activity. Extensive research into CD24's involvement in these disorders may lead to targeted therapies including the development of anti-CD24 antibodies for therapeutic interventions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

May have a pivotal role in cell differentiation of different cell types. Signaling could be triggered by the binding of a lectin-like ligand to the CD24 carbohydrates, and transduced by the release of second messengers derived from the GPI-anchor. Modulates B-cell activation responses. Promotes AG-dependent proliferation of B-cells, and prevents their terminal differentiation into antibody-forming cells (PubMed : 11313396). In association with SIGLEC10 may be involved in the selective suppression of the immune response to danger-associated molecular patterns (DAMPs) such as HMGB1, HSP70 and HSP90. Plays a role in the control of autoimmunity (By similarity).
See full target information CD24

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

Journal of translational medicine 22:1036 PubMed39558364

2024

Isolation and identification of patient-derived liver cancer stem cells and development of personalized treatment strategies.

Applications

Unspecified application

Species

Unspecified reactive species

Tingting Guo,Shuai Zhang,Weiping Zeng,Yan Liang,Jinghe Xie,ShouPei Liu,Yaqi Qiu,Yingjie Fu,Yimeng Ou,Keqiang Ma,Bailin Wang,Weili Gu,Yuyou Duan

Biology direct 19:109 PubMed39529141

2024

miR-630 as a therapeutic target in pancreatic cancer stem cells: modulation of the PRKCI-Hedgehog signaling axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Zou,Sha Yang,Chongwu He,Lei Deng,Bangran Xu,Shuai Chen

BMC cancer 24:1370 PubMed39516821

2024

NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-β/Smad signaling pathway in MCF-7 tumor spheroid.

Applications

Unspecified application

Species

Unspecified reactive species

So-Hyun Yoon,Sangeun Lee,Hoe Suk Kim,Junhyuk Song,Moonjou Baek,Seungyeon Ryu,Han-Byoel Lee,Hyeong-Gon Moon,Dong-Young Noh,Sangyong Jon,Wonshik Han

European journal of immunology 54:e2451178 PubMed39444061

2024

CD24 regulates liver immune response and ameliorates acute hepatic injury through controlling hepatic macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Zheng,Jun Xiao,Yatong Fan,Honggang Zheng,Hongyu Liu,Jie Xiang,Lei Hai,Yan Wang,Xuejun Zhang

Molecular carcinogenesis 64:33-43 PubMed39400383

2024

microRNA-2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2.

Applications

Unspecified application

Species

Unspecified reactive species

Qing Xia,Guanghua Liu,Wenbo Lin,Jin Zhang

Cell death & disease 15:313 PubMed38702326

2024

LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Liu,Changsheng Yan,Shaohua Xu

Theranostics 14:892-910 PubMed38169544

2024

Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qingyang Zhang,Yu-Man Tsui,Vanilla Xin Zhang,Anna Jingyi Lu,Joyce Man-Fong Lee,Eva Lee,Gary Cheuk-Hang Cheung,Po-Man Li,Elaine Tin-Yan Cheung,Nam-Hung Chia,Irene Lai-Oi Lo,Albert Chi-Yan Chan,Tan-To Cheung,Irene Oi-Lin Ng,Daniel Wai-Hung Ho

Breast cancer (Dove Medical Press) 15:967-984 PubMed38164371

2023

CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1.

Applications

Unspecified application

Species

Unspecified reactive species

Xudong Zhu,Jiahui Yu,Fulu Ai,Yue Wang,Wu Lv,Guilin Yu,Xiankui Cao,Jie Lin

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2304761 PubMed38145353

2023

Enzymatically Bioactive Nucleus Pulposus Matrix Hydrogel Microspheres for Exogenous Stem Cells Therapy and Endogenous Repair Strategy to Achieve Disc Regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Yizhong Peng,Xuanzuo Chen,Qimin Zhang,Sheng Liu,Wei Wu,Kanglu Li,Hui Lin,Xiangcheng Qing,Yan Xiao,BaiChuan Wang,Daping Quan,Shiqing Feng,Zilong Rao,Ying Bai,Zengwu Shao

MedComm 4:e357 PubMed37667739

2023

Zyxin inhibits the epithelial-mesenchymal transition process in gastric cancer by upregulating SIRT1.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Lou,Sha Geng,Wei He,Song-Bai Liu,Xinghong Shi,Ying Chang,Shiyuan Han,Panting Qian,Hesham M Amin,Yao-Hua Song,Yangxin Li,Jin Zhou
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com